Desmopressin Acetate (DDAVP)

Company
Rhone Poulenc Rorer

Approval Status
Approved March 1998

Treatment for
nocturnal enuresis

Possible similar drugs
Desmopressin Acetate

Areas
Pediatrics

A tablet formulation of DDAVP (desmopressin acetate) has been approved for managing primary nocturnal enuresis in patients age six and over. DDAVP is a synthetic form of vasopressin that has been available in nasal spray since 1989. Vasopressin regulates water balance and urine production.

Desmopressin_acetate_425 Drug Information

The Desmopressin_acetate_425 drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.

Scroll to top